Anna-Lise Williamson
#110,269
Most Influential Person Now
Professor of Virology
Anna-Lise Williamson's AcademicInfluence.com Rankings
Anna-Lise Williamsonbiology Degrees
Biology
#14292
World Rank
#18005
Historical Rank
Virology
#362
World Rank
#370
Historical Rank
Download Badge
Biology
Why Is Anna-Lise Williamson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Anna-Lise Williamson MASSAf is a Professor of Virology at the University of Cape Town. Williamson obtained her PhD from the University of the Witwatersrand in 1985. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. These vaccines have been introduce in phase 1 of clinical trial. Williamson has published more than 120 papers.
Anna-Lise Williamson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. (2007) (217)
- An association between HIV‐1 subtypes and mode of transmission in Cape Town, South Africa (1997) (172)
- Oral Immunogenicity of Human Papillomavirus-Like Particles Expressed in Potato (2003) (170)
- HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study (2006) (151)
- Human Papillomavirus Infection and Cervical Disease in Human Immunodeficiency Virus-1–Infected Women (2008) (133)
- Evidence of Unique Genotypes of Beak and Feather Disease Virus in Southern Africa (2004) (111)
- Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa (2013) (110)
- Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA (2001) (107)
- Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa (2009) (106)
- Expression of HIV-1 antigens in plants as potential subunit vaccines (2008) (104)
- Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16 (2005) (100)
- Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi (2003) (95)
- Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. (2004) (87)
- Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16 (2003) (85)
- Impact of Mucosal Inflammation on Cervical Human Immunodeficiency Virus (HIV-1)-Specific CD8 T-Cell Responses in the Female Genital Tract during Chronic HIV Infection (2008) (82)
- The Capsid Protein of Beak and Feather Disease Virus Binds to the Viral DNA and Is Responsible for Transporting the Replication-Associated Protein into the Nucleus (2006) (77)
- The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women (2006) (77)
- Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract (2009) (76)
- Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies. (1999) (74)
- Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. (2006) (74)
- Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study (2009) (73)
- Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. (2012) (73)
- Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. (2009) (72)
- Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. (2005) (71)
- Evidence of ancient papillomavirus recombination. (2006) (66)
- The Effectiveness of Carraguard, a Vaginal Microbicide, in Protecting Women against High-Risk Human Papillomavirus Infection (2011) (66)
- Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. (2005) (65)
- Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits (2012) (65)
- HIV-1 subtypes in different risk groups in South Africa (1995) (64)
- Diverse and High Prevalence of Human Papillomavirus Associated with a Significant High Rate of Cervical Dysplasia in Human Immunodeficiency Virus–Infected Women in Johannesburg, South Africa (2009) (63)
- Determinants of sexual activity and its relation to cervical cancer risk among South African Women (2007) (62)
- Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer (2003) (62)
- The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa (2015) (61)
- Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial. (2006) (61)
- Limited Pap screening associated with reduced risk of cervical cancer in South Africa. (2003) (61)
- High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia (2003) (57)
- Cervical and oral human papillomavirus types in HIV‐1 positive and negative women with cervical disease in South Africa (2008) (57)
- Production of complex viral glycoproteins in plants as vaccine immunogens (2018) (55)
- The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. (2002) (55)
- The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population (2007) (53)
- Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding. (2011) (53)
- Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) (2003) (53)
- Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C. (2008) (51)
- Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV (2018) (51)
- High-Risk Human Papillomavirus Is Associated with HIV Acquisition among South African Female Sex Workers (2011) (49)
- Papillomavirus Subtypes Are Natural and Old Taxa: Phylogeny of Human Papillomavirus Types 44 and 55 and 68a and -b (2005) (49)
- High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns (2018) (49)
- Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle. (2002) (48)
- Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa (1997) (48)
- Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. (2010) (47)
- Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study (2018) (47)
- Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status (2015) (47)
- Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. (2010) (45)
- Setting up a platform for plant-based influenza virus vaccine production in South Africa (2012) (45)
- Phylogenetic and histological variation in avipoxviruses isolated in South Africa (2013) (44)
- Two Methods of Self-Sampling Compared to Clinician Sampling to Detect Reproductive Tract Infections in Gugulethu, South Africa (2006) (44)
- Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus‐like particles in South African women with cervical cancer and cervical intraepithelial neoplasia (2000) (44)
- Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons. (2009) (44)
- Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation. (2014) (42)
- Optimization of chimeric HIV‐1 virus‐like particle production in a baculovirus‐insect cell expression system (2009) (42)
- Agreement between Self- and Clinician-Collected Specimen Results for Detection and Typing of High-Risk Human Papillomavirus in Specimens from Women in Gugulethu, South Africa (2007) (42)
- Combined single‐clade candidate HIV‐1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference (2007) (42)
- Cervical Human Papillomavirus (HPV) Infection in South African Women: Implications for HPV Screening and Vaccine Strategies (2007) (42)
- Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer (2003) (41)
- Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector. (2003) (41)
- A prime-boost immunisation regimen using recombinant BCG and Pr55(gag) virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons. (2009) (41)
- Cervical Human Papillomavirus (HPV) Infection and HPV Type 16 Antibodies in South African Women (2007) (40)
- A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles. (1999) (40)
- Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice. (2004) (40)
- High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa (2016) (39)
- Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa (2020) (39)
- Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia (2001) (38)
- Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town (1994) (38)
- The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses (2014) (38)
- Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer (2005) (36)
- More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population (2006) (36)
- Co‐expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants (2020) (36)
- Female genital tract inflammation, HIV co-infection and persistent mucosal Human Papillomavirus (HPV) infections. (2016) (36)
- Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge. (2006) (36)
- Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media (2012) (35)
- Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. (2007) (35)
- CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women (2010) (35)
- Detection of genital human papillomaviruses by polymerase chain reaction amplification with degenerate nested primers (1991) (35)
- Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans (2009) (34)
- The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. (2000) (34)
- HIV-1 subtype C Pr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine. (2008) (33)
- A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice. (2008) (33)
- The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). (2015) (33)
- Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection (2019) (33)
- Phylogenetic analysis of three genes of Penguinpox virus corresponding to Vaccinia virus G8R (VLTF-1), A3L (P4b) and H3L reveals that it is most closely related to Turkeypox virus, Ostrichpox virus and Pigeonpox virus (2009) (33)
- Comparison of cervical and blood T‐cell responses to human papillomavirus‐16 in women with human papillomavirus‐associated cervical intraepithelial neoplasia (2006) (32)
- Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing (2014) (32)
- Papanicolaou smears and cervical inflammatory cytokine responses (2007) (32)
- Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia (2007) (31)
- Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice (2009) (31)
- Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection (2018) (31)
- Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix (2003) (30)
- Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains (2016) (30)
- A deletion and point mutation study of the human papillomavirus type 16 major capsid gene. (2006) (30)
- A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV) (2011) (29)
- Human Papillomavirus (HPV) Infection in Southern Africa: Prevalence, Immunity, and Vaccine Prospects (2002) (29)
- Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-Infected and HIV-Uninfected Adolescent Females in South Africa (2014) (28)
- Justification for the inclusion of Gag in HIV vaccine candidates (2016) (28)
- HPV genotypes in women with squamous intraepithelial lesions and normal cervixes participating in a community-based microbicide study in Pretoria, South Africa. (2009) (28)
- Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals. (2020) (28)
- Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells (2012) (27)
- Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. (2008) (27)
- The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection (2019) (27)
- Strategies for the prevention of cervical cancer by human papillomavirus vaccination. (2005) (27)
- The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples. (2013) (27)
- Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens (2019) (27)
- Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus (2019) (26)
- A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV‐seropositive women from Johannesburg, South Africa (2017) (26)
- Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model (2013) (26)
- Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon. (2007) (26)
- The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. (2006) (26)
- Immunogenicity of an HPV-16 L2 DNA vaccine. (2009) (25)
- Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap (2016) (25)
- Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production (2010) (24)
- HIV‐1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV‐16 antibodies in female sex workers (2009) (24)
- The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine (2011) (23)
- High risk human papillomavirus persistence among HIV-infected young women in South Africa. (2015) (23)
- The detection of human papillomavirus in oesophageal lesions. (1991) (23)
- Abrogation of contaminating RNA activity in HIV-1 Gag VLPs (2011) (23)
- The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform (2020) (23)
- No relationship observed between human p53 codon‐72 genotype and HPV‐associated cervical cancer in a population group with a low arginine‐72 allele frequency (2007) (23)
- Vaccination strategies for the prevention of cervical cancer (2005) (22)
- Risk factors for oral human papillomavirus in heterosexual couples in an African setting. (2014) (22)
- Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice (2013) (22)
- Comparative analysis of avian poxvirus genomes, including a novel poxvirus from lesser flamingos (Phoenicopterus minor), highlights the lack of conservation of the central region (2017) (22)
- single‐cell cytokine analysis allows detection of cervical T‐cell responses against human papillomavirus type 16 L1 in women infected with genital HPV (2002) (22)
- Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa. (2020) (22)
- Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa. (2003) (21)
- Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice (2017) (21)
- Typing of human papillomaviruses in cervical intraepithelial neoplasia grade 3 biopsies from cape town (1989) (21)
- The penile microbiota of Black South African men: relationship with human papillomavirus and HIV infection (2020) (20)
- Factors associated with the composition and diversity of the cervical microbiota of reproductive-age Black South African women: a retrospective cross-sectional study (2019) (19)
- Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis. (2016) (19)
- Seroresponses to virus‐like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San People of Southern Africa (2000) (19)
- The Penile Microbiota in Uncircumcised and Circumcised Men: Relationships With HIV and Human Papillomavirus Infections and Cervicovaginal Microbiota (2020) (18)
- High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women (2016) (18)
- CD4 T Cell Depletion at the Cervix during HIV Infection Is Associated with Accumulation of Terminally Differentiated T Cells (2011) (18)
- Inflammatory Cytokine Profiles of Semen Influence Cytokine Responses of Cervicovaginal Epithelial Cells (2018) (18)
- Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia (2016) (17)
- Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women (2016) (17)
- Avian Poxvirus Epizootic in a Breeding Population of Lesser Flamingos (Phoenicopterus minor) at Kamfers Dam, Kimberley, South Africa (2011) (17)
- Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants (2016) (17)
- South African HIV-1 vaccine candidates - the journey from the bench to clinical trials. (2012) (17)
- Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model (2018) (17)
- The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256 (2018) (17)
- Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening (2019) (17)
- Vaccine farming in Cape Town (2011) (16)
- Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease. (2008) (16)
- CASP8 promoter polymorphism is associated with high‐risk HPV types and abnormal cytology but not with cervical cancer (2011) (16)
- Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa (2017) (16)
- Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women (2014) (15)
- The novel capripoxvirus vector lumpy skin disease virus efficiently boosts modified vaccinia Ankara human immunodeficiency virus responses in rhesus macaques. (2014) (15)
- CCR5 expression, haplotype and immune activation in protection from infection in HIV‐exposed uninfected individuals in HIV‐serodiscordant relationships (2017) (15)
- A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents. (2013) (15)
- Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas (2008) (15)
- Detection of natural infection with Mycobacterium intracellulare in healthy wild-caught Chacma baboons (Papio ursinus) by ESAT-6 and CFP-10 IFN-γ ELISPOT tests following a tuberculosis outbreak (2008) (14)
- High Rate of Multiple Concurrent Human Papillomavirus Infections among HIV-Uninfected South African Adolescents. (2013) (13)
- The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research. (2005) (13)
- The complete genome sequence of the lumpy skin disease virus vaccine Herbivac LS reveals a mutation in the superoxide dismutase gene homolog (2019) (13)
- Genome Sequences of Three African Swine Fever Viruses of Genotypes I, III, and XXII from South Africa and Zambia, Isolated from Ornithodoros Soft Ticks (2020) (13)
- The agreement between cervical abnormalities identified by cytology and detection of high-risk types of human papillomavirus. (2006) (13)
- Human papillomavirus genotypes and clinical management of genital warts in women attending a colposcopy clinic in Cape Town, South Africa. (2015) (13)
- Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa (2016) (12)
- An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice (2009) (12)
- Isolation and characterization of T cells from semen. (2012) (12)
- Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas. (2007) (12)
- HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice (2016) (12)
- HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice (2010) (11)
- Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model (2015) (11)
- Human Leukocyte Antigen (HLA) Class II -DRB1 and -DQB1 Alleles and the Association with Cervical Cancer in HIV/HPV Co-Infected Women in South Africa (2019) (11)
- High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa (2021) (11)
- Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women (2020) (11)
- The use of the polymerase chain reaction for the detection of human papillomavirus type 13. (1991) (11)
- Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa (2021) (11)
- Altered phenotype and function of NK cells infiltrating human papillomavirus (HPV)-associated genital warts during HIV infection. (2014) (11)
- The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen (2014) (11)
- South African bovine ephemeral fever virus glycoprotein sequences are phylogenetically distinct from those from the rest of the world (2020) (10)
- Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer (2003) (10)
- Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa (2021) (10)
- A fas gene polymorphism influences herpes simplex virus type 2 infection in South African women (2010) (10)
- Human papillomavirus types in HIV seropositive men with penile warts in Johannesburg, South Africa (2011) (10)
- Impact of chemokine C–C ligand 27, foreskin anatomy and sexually transmitted infections on HIV-1 target cell availability in adolescent South African males (2019) (9)
- Calreticulin co-expression supports high level production of a recombinant SARS-CoV-2 spike mimetic in Nicotiana benthamiana (2020) (9)
- Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial (2017) (9)
- Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa (2020) (9)
- Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women (2020) (9)
- Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles (2020) (9)
- Human papillomavirus in normal cervical smears from Cape Town. (1996) (8)
- Evolutionary dynamics of ten novel Gamma-PVs: insights from phylogenetic incongruence, recombination and phylodynamic analyses (2019) (8)
- High diversity of alpha, beta and gamma human papillomaviruses in genital samples from HIV-negative and HIV-positive heterosexual South African men (2017) (8)
- Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana (2021) (8)
- DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies (2017) (8)
- Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteria. (2009) (8)
- Discovery, characterisation and genomic variation of six novel Gammapapillomavirus types from penile swabs in South Africa (2019) (8)
- Removal of bovine viral diarrhea virus (BVDV) from lumpy skin disease virus (LSDV) vaccine stocks by passage on chorioallantoic membranes of fertilized hens' eggs. (2019) (7)
- Typing and molecular characterization of human papillomaviruses in genital warts from South African women (1991) (7)
- Influence of the lumpy skin disease virus (LSDV) superoxide dismutase homologue on host transcriptional activity, apoptosis and histopathology. (2020) (7)
- The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa (2015) (7)
- Genome Sequences of Three African Swine Fever Viruses of Genotypes IV and XX from Zaire and South Africa, Isolated from a Domestic Pig (Sus scrofa domesticus), a Warthog (Phacochoerus africanus), and a European Wild Boar (Sus scrofa) (2020) (7)
- The Development of HIV‐1 Subtype C Vaccines for Southern Africa (2002) (7)
- Transkingdom Analysis of the Female Reproductive Tract Reveals Bacteriophages form Communities (2021) (7)
- Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity (2020) (6)
- Human Papillomavirus Genotype Distribution among Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Women in Soweto, South Africa (2008) (6)
- Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women (2017) (6)
- Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector (2021) (6)
- The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF) (2021) (6)
- Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection (2021) (5)
- Recombination Between High-Risk Human Papillomaviruses and Non-Human Primate Papillomaviruses: Evidence of Ancient Host Switching Among Alphapapillomaviruses (2020) (5)
- Xenogenic rolling-circle replication of a synthetic beak and feather disease virus genomic clone in 293TT mammalian cells and Nicotiana benthamiana. (2017) (5)
- Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women (2019) (5)
- Correction: Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice (2013) (5)
- Human papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa (2017) (5)
- Host Immune Responses Associated with Clearance or Persistence of Human Papillomavirus Infections (2016) (5)
- Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens (2020) (5)
- Investigating Constraints Along the Plant Secretory Pathway to Improve Production of a SARS-CoV-2 Spike Vaccine Candidate (2022) (5)
- High level of agreement between clinician-collected and self-collected samples for HPV detection among South African adolescents. (2012) (5)
- Phylogenetic Analysis of South African Bovine Leukaemia Virus (BLV) Isolates (2020) (4)
- Partner HIV serostatus impacts viral load, genital HIV shedding and immune activation in HIV-infected individuals. (2019) (3)
- Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV (2021) (3)
- Complete Genome Sequences of Four Novel Human Gammapapillomavirus Types, HPV-219, HPV-220, HPV-221, and HPV-222, Isolated from Penile Skin Swabs from South African Men (2018) (3)
- High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention (2022) (3)
- Women families and the future. Sexual relationships and marriage worldwide.[Fact sheet] (1995) (3)
- Effect of Human Papillomavirus (HPV) Education Intervention on HPV Knowledge and Awareness Among High School Learners in Eastern Cape Province of South Africa (2021) (3)
- Sequence variation in the L1 gene of human papillomavirus type 16 from Africa (2005) (3)
- Identification of the Human Papillomavirus Genotypes, According to the Human Immunodeficiency Virus Status in a Cohort of Women from Maputo, Mozambique (2021) (3)
- Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein (2022) (2)
- AIDS dissidents aren't victims — but the people their ideas kill will be (2000) (2)
- Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array (2022) (2)
- The Cape Town declaration on human papillomavirus related disease☆ (2017) (2)
- S12.1 Human Papillomavirus Vaccines - Correlates of Protection Are Not Defined (2013) (2)
- Augmenting glycosylation‐directed folding pathways enhances the fidelity of HIV Env immunogen production in plants (2022) (2)
- Protein of HPV-6 and HPV-16 Neutralizing Epitope for the L 2 Minor Capsid Common ( HPV-16 ) L 1 Particles Presenting the Chimeric Human Papillomavirus Type 16 (2003) (2)
- Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV. (2015) (1)
- Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages (2021) (1)
- High risk HPV persistence among HIV-infected young women in South Africa (2015) (1)
- Genital inflammatory status and the innate immune response to contraceptive initiation (2022) (1)
- A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters (2023) (1)
- P15.04 Genital tract cellular activation and inflammation associated with highly prevalent sexually transmitted infections and bacterial vaginosis in adolescent women at risk for hiv infection (2015) (1)
- Stability studies of HIV-1 Pr55gagvirus-like particles made in insect cells after storage in various formulation media (2012) (1)
- Viruses, variants and vaccines (2021) (1)
- Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen (2012) (1)
- A single dose of SAAVI MVA-C reboosts rhesus macaques after more than 3 years post DNA-MVA prime-boost vaccination (2012) (1)
- Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice (2022) (1)
- Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity. (2020) (1)
- The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses (2014) (1)
- South African bovine ephemeral fever virus glycoprotein sequences are phylogenetically distinct from those from the rest of the world (2020) (1)
- Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits (2012) (1)
- Papanicolaou Smears Induce Partial Immunity Against Sexually Transmitted Viral Infections (2007) (1)
- Microbiological and behavioral determinants of genital HPV infections among adolescent girls and young women warrant the need for targeted policy interventions to reduce HPV risk (2022) (0)
- Lumpy Skin Disease—An Emerging Cattle Disease in Europe and Asia (2023) (0)
- O18.3 Adolescents in south africa and assessment of hiv risk: knowing who we are trying to protect (2015) (0)
- Edinburgh Research Explorer Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16 (2018) (0)
- A prime-boost immunization with rBCG expressing HIV-1 Gag, RT and gp120 and SAAVI MVA-C elicits immune responses in blood and MALT of rhesus macaques (2012) (0)
- A pantothenate suxotroph of BCG rxpressing Gag confers enhanced HIV-specific immunogenicity compared to wildtype and perfingolysin expressing strains (2012) (0)
- The penile microbiota of Black South African men: relationship with human papillomavirus and HIV infection (2020) (0)
- Comparative analysis of avian poxvirus genomes, including a novel poxvirus from lesser flamingos (Phoenicopterus minor), highlights the lack of conservation of the central region (2017) (0)
- Nonhuman Primate Model Prime-Boost HIV Vaccine Candidate in a Mycobacterium bovis BCG-VLP Robust Immunity to an Auxotrophic (2014) (0)
- Selecting HPV genotypes to optimize performance of GeneXpert and linear array in South Africa (2019) (0)
- Development of a dual vaccine against East Coast fever and lumpy skin disease (2023) (0)
- TheGenetic Drift ofHuman Papillomavirus Type16Isa MeansofReconstructing Prehistoric ViralSpreadandthe MovementofAncient Human Populations (1993) (0)
- Impact of chemokine C–C ligand 27, foreskin anatomy and sexually transmitted infections on HIV-1 target cell availability in adolescent South African males (2019) (0)
- Impact of Mucosal Inflammation on Cervical Human Immunodeficiency Virus (HIV-1)-Specific CD8 T-Cell Responses in the Female Genital Tract during Chronic HIV Infection (cid:1) (2008) (0)
- Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model (2015) (0)
- Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening (2019) (0)
- Human Leukocyte Antigen ( HLA ) Class II-DRB 1 and-DQB 1 Alleles and the Association with Cervical Cancer in HIV / HPV Co-Infected Women in South Africa (2019) (0)
- Short Communication Evidence of ancient papillomavirus recombination (2006) (0)
- Prokaryotic Expression and Purification of HIV-1 Subtype C Gag for Use in ELISAs (2008) (0)
- Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines (2023) (0)
- Impact of the innate environment on maintaining memory T-cell numbers in the female genital tract: implications for mucosal vaccine efficacy? (2012) (0)
- Two different types of human papillomavirus in a patient with carcinomas of the vulva and cervix. (1997) (0)
- Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus. (2022) (0)
- Evolutionary dynamics of ten novel Gamma-PVs: insights from phylogenetic incongruence, recombination and phylodynamic analyses (2019) (0)
- Oral human papillomavirus (HPV) infection is associated with partner's genital HPV infection (2014) (0)
- Inflammation in the male genital tract: implications for HIV acquisition and transmission (2012) (0)
- Genome Sequences of Three African Swine Fever Viruses of Genotypes IV and XX from Zaire and South Africa, Isolated from a Domestic Pig (<named-content content-type='genus-species'>Sus scrofa domesticus</named-content>), a Warthog (<named-content content-type='genus-species'>Phacochoerus africanus</n (2020) (0)
- P19-53 LB. Priming with recombinant BCG expressing HIV-1 Gag or RT and boosting with recombinant MVA induces an effective immune response in mice (2009) (0)
- The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa (2015) (0)
- Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection (2018) (0)
- Robust immunity to an auxotrophic BCG-VLP prime-boost (2013) (0)
This paper list is powered by the following services:
Other Resources About Anna-Lise Williamson
What Schools Are Affiliated With Anna-Lise Williamson?
Anna-Lise Williamson is affiliated with the following schools:
